Download PDF

Other users also viewed these articles

Remission of Rheumatoid Arthritis and Primary Biliary Cholangitis After Treatment With Tocilizumab Soraia Azevedo; Joana Sousa-Neves; Joana Ramos Rodrigues; Daniela Peixoto; José Tavares-Costa; Filipa Teixeira;
Reumatol Clin. 2021;17:364-5
Effectiveness of intravenous tocilizumab in routine clinical practice in a cohort of Costa Rican patients with rheumatoid arthritis Mauricio Cordero-Alfaro; Carlos León-Céspedes; Allan Ramos-Esquivel;
Reumatol Clin. 2021;17:329-34
The impact of COVID-19 and other factors on the usage status of the biologic drug therapies for rheumatoid arthritis: A study from Vietnam Hai-Binh Bui; Hong-Thinh Lai; Thanh-Lam Nguyen; Thuy-Duong Vu; Nhat-Le Bui; Van-Hung Nguyen; Thi-To-Chau Tran; Thi-Phuong-Thuy Nguyen; Thi-Ngoc-Lan Nguyen; Jaffar A. Al-Tawfiq; Dinh-Toi Chu;
Reumatol Clin. 2024;20:128-35